Human cytomegalovirus (HCMV) is a betaherpesvirus that infects the majority of the population and is best known for causing birth defects and health problems in immunocompromised individuals such as transplant recipients and AIDS patients (8). Seropositivity for HCMV also correlates with poorer clinical outcomes for inflammatory bowel diseases, allograft rejection, atherosclerosis, and coronary restenosis following angioplasty. There are a number of reports of increased p53 and phosphorylated p53 in HCMV-infected cells and cells expressing the HCMV immediate-early (IE) protein 51, 58, 60) . However, the detailed mechanism of such an increase and its biological significance are not well understood.
Human cytomegalovirus (HCMV) is a betaherpesvirus that infects the majority of the population and is best known for causing birth defects and health problems in immunocompromised individuals such as transplant recipients and AIDS patients (8) . Seropositivity for HCMV also correlates with poorer clinical outcomes for inflammatory bowel diseases, allograft rejection, atherosclerosis, and coronary restenosis following angioplasty. There are a number of reports of increased p53 and phosphorylated p53 in HCMV-infected cells and cells expressing the HCMV immediate-early (IE) protein IE2-86 (32, 51, 58, 60) . However, the detailed mechanism of such an increase and its biological significance are not well understood.
The effects of HCMV on coronary smooth muscle cells were correlated with p53 accumulation and IE2-86-mediated inhibition of p53 functioning (60) . This was evidenced by reports that IE2-86 expression in HCMV-infected cells mirrored p53 induction and IE2-86 coimmunoprecipitated p53 (59) . IE2-86 also blocked reporter gene activity from p53-responsive promoters without interfering with p53 binding to its target DNA sequences (61) . Steady-state levels of p21, a cyclin-dependent kinase inhibitor whose levels are indicative of p53 transcriptional activity, are decreased in HCMV-infected cells (12, 23, 52) . However, either IE1-72 or IE2-86 alone increased the relative amounts of p21 in transfected cells (10, 58) . p53 is a cellular tumor suppressor protein that is induced in response to a variety of stresses, including cellular DNA damage, and is critical in arresting cell growth and the induction of apoptosis (41) . Levels of p53 are normally maintained in a regulatory circuit with mdm2. p53 induces the transcription of mdm2, a ubiquitin ligase that targets p53 for proteasomal degradation (49) . A variety of posttranslational modifications to p53, such as serine 15 phosphorylation by ataxia telangiectasiamutated and Rad 3-related kinases, are capable of breaking the p53-mdm2 regulatory loop and increasing levels of p53 (3) .
HCMV IE proteins are promiscuous transactivators with multiple functions (11) . They block apoptosis (71) and are capable of stimulating quiescent cells into G 1 /S phase (70) and arresting cell cycle progression at the same border (43) . IE1-72 and IE2-86 bind and phosphorylate retinoblastoma (Rb) family members, resulting in the upregulation of cyclin E/cdk2 kinase activity and E2F/DP transcription factor release (47, 54, 64, 68) , respectively. Cells transfected with IE2-86 show predominant activation of E2F-responsive genes (57) , while IE1-72 causes the release of cyclin E/cdk2 from its inactive complex (68) . IE1-72 is a serine/threonine protein kinase (53) that appears to be dispensable for HCMV replication under high multiplicities of infection (29) , while IE2-86 is not (46) . Either IE1-72 or IE2-86 can induce p53 (51) , but IE2-86 is considered the dominant factor that induces and inactivates p53 during HCMV infection for the reasons described above.
Productive infection for a number of DNA viruses is accompanied by increased levels of inactive p53 (15) . While it remains unclear how these viruses induce p53, it is likely that upregulation of p53, particularly as an effector of apoptosis, is not conducive to viral replication. Numerous DNA viruses encode proteins that undermine p53 functioning. The best known of these include the adenovirus E1 proteins, human papillomavirus E6 and E7, and the large T antigen of polyomaviruses (41) .
While a great deal of attention has been paid to the effects of virus infection upon p53, relatively little work has been done to characterize mdm2 in virus-infected cells. Knockout experiments suggest that mdm2 is at least as biologically important as p53. p53-negative mice display mild phenotypes and are susceptible to spontaneous tumors (19) . Mdm2 knockouts are embryonic lethal and can be rescued by codeletion of p53 (36, 50) . While mdm2 levels can indicate p53 transcriptional activity, mdm2 is its own ubiquitin ligase and a number of p53-independent functions have been described for mdm2, such as cell cycle regulation, differentiation, and transcriptional transactivation (25) .
IE2-86, p53, and mdm2 are all known to bind and/or affect a variety of proteins associated with transcriptional activation and cell cycle regulation. For example, both IE2-86 and mdm2 bind to p53, Rb, TATA box-binding protein, Sp1, and p300/ CBP (11, 25) . Mdm2 links the Rb and p53 tumor suppressor pathways as a trimeric complex of Rb-mdm2-p53 (31) . Many biologically relevant aspects of the interactions among these proteins and their corresponding pathways remain unresolved.
There is peripheral evidence to suggest that mdm2 may be either upregulated or downregulated in HCMV-infected cells. HCMV infection proceeds with the phosphorylation of Akt, Rb, and mitogen-activated protein kinases ERK1 and -2 (32) (33) (34) 55) . Each of these events has induced mdm2 in other systems. Inhibition of mdm2 resulted in p21 induction independently of p53 (69) , yet p21 is downregulated in HCMVinfected cells (12, 52) . These observations suggest that mdm2 might be upregulated in response to HCMV infection. However, the increase in p53 levels and the lack of p53 transcriptional activity in HCMV-infected cells (60, 61) suggest that mdm2 might be downregulated in HCMV infection. Also, Sp1 transcription factors are induced in HCMV-infected cells (67) and mdm2 has been shown to inhibit Sp1-mediated transcription (35) .
We are aware of only one report that has examined the status of mdm2 during HCMV infection. In situ hybridization and immunohistochemistry of human tissue sections correlated p53 induction with HCMV infection, yet infected cells demonstrated mutually exclusive patterns of either p21 or mdm2 induction (26) . This study was initiated as an inquiry into the mechanism of p53 accumulation in HCMV-infected fibroblasts and to examine the fate of mdm2 in cells productively infected with HCMV and its implications for the effects of this virus upon the p53-mdm2 regulatory loop.
MATERIALS AND METHODS
Reagents. MG132 was purchased from Sigma (St. Louis, MO). Antibodies to p53 (DO-1 and FL-393) and mdm2 (SMP-14) were purchased from Santa Cruz (Santa Cruz, CA). Antibodies to HCMV IE1-72 and IE2-86 proteins were prepared as described previously (39) . Antibody to ␤-actin (CP01) was from Oncogene (San Diego, CA). Protein G-Sepharose and glutathione-Sepharose 4B were from Amersham Biosciences (Piscataway, NJ). All other reagents were from Sigma and were of at least reagent grade.
Plasmids. pCMV-HDM2 and pcDNA3-myc3-HDM2 were gifts from Yue Xiong. (Elsewhere in this publication we employ the term mdm2 regardless of the organism of origin.) The reporter plasmid expressing firefly luciferase from the cyclin A promoter (WT-Luc) was prepared as described previously (14) . Control plasmid expressing Renilla luciferase from a herpes simplex virus thymidine kinase promoter (pRL-TK) was purchased from Promega (Madison, WI).
pcDNA3IE2 containing IE2-86 cDNA was used as a template for PCR to produce full-length protein and the following deletions: IE2-26-579, encoding amino acids (aa) 26 to 579; IE2-D325-448, encoding aa 1 to 324 and 449 to 579; IE2-1-324, encoding aa 1 to 324; and IE2-1-538, encoding aa 1 to 538. A Cterminal Flag tag was incorporated into the primer design of each construct. The primers used to generate deletion mutants were IE2N (5Ј-CGACGGATCCAT GGAGTCCTCTGCCAAGAG-Ј3), IE2C (5Ј-GTCGAATTCCTTGTCGTCGT CATCCTTGTAGTCCTGAGACTTGTTCCTC-3Ј), IE2-26-579N (5Ј-CGACG GATCCATGGAGACACCCGTGACCAAGG-3Ј), IE2-1-324C (5Ј-GTCGAATT CCTTGTCGTCGTCATCCTTGTAGTCCTTCTTGCGGGGTCC-3Ј), IE2-D325-448N (5Ј-GGACCCCGCAAGAAGGTGACACATCCACC-3Ј), IE2-D325-448C (5Ј-CGGGTGGATGTGTCACCTTCTTGCGGGGTCC-3Ј), and IE2-1-538C (5Ј-GTGGAATTCCTTGTCGTCGTCATCCTTGTAGTCCTCGTAGATA GGCAGC-3Ј).
Each PCR fragment contained a BamHI restriction site at the 5Ј terminus and a 3Ј-terminal EcoRI restriction site. These restriction sites were used to insert PCR fragments into the multiple cloning sequence of the pcDNA3 expression vector to construct Flag-tagged pcDNA3IE2f, pcDNA3IE2-26-579f, pcDNA3IE2-D325-448f, pcDNA3IE2-1-324f, and pcDNA3IE2-1-538f. Ligation of the same fragments into plasmid pGEX-2T resulted in N-terminal glutathione S-transferase (GST) expression vectors pGEX-2TIE2f, pGEX-2TIE2-26-579f, pGEX-2TIE2-D325-448f, pGEX-2TIE2-1-324f, and pGEX-2TIE2-1-538f.
Cell culture. Human embryonic lung fibroblasts (HEL 299), BHK-21, and p53-null H1299 cells were obtained from the American Type Culture Collection (Manassas, VA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 5 to 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin at 37°C in an atmosphere of 6% CO 2 . Cells were infected with HCMV Towne strain (passages 36 to 42) that had been purified through a sucrose cushion to eliminate cytokines and growth factor contamination at a multiplicity of infection (MOI) of 2 to 5 PFU/cell.
Western blot assays. Following treatments and incubation periods in 100-mm dishes, cell monolayers were harvested by washing in phosphate-buffered saline (PBS) and scraping in 2ϫ sodium dodecyl sulfate (SDS) loading buffer. Samples were boiled and proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to Immobilon-P membranes (Millipore; Bedford, MA). Membranes were blocked for 30 min in 5% (wt/vol) nonfat dry milk in PBS with 0.1% Tween 20 (PBS-T). Blots were probed with primary antibodies overnight at 4°C. Membranes were washed with PBS-T, probed with secondary horseradish peroxidase-conjugated antibodies, and then washed and developed by enhanced chemiluminescence (ECL) according to the manufacturer's instructions (Amersham). p53 ubiquitination assay. HEL cells incubated in DMEM without serum for 48 h were infected with HCMV at an MOI of 2 to 5 PFU/cell. Fourteen hours postinfection, MG132 was added to cells to a final concentration of 30 M. Cells were harvested following 10 hours treatment with MG132, corresponding to 24 h postinfection.
Immunoprecipitation for p53 ubiquitination. The p53-null H1299 cells were transfected with vectors encoding mdm2, p53, IE1-72, IE2-86, and IE2-86 deletions in the combinations indicated in the figure legends using Effectene (QIA-GEN, Valencia, CA) according to the manufacturer's instructions. Sixty-two hours posttransfection, the proteasome inhibitor MG132 was added to a final concentration of 30 M and presumably ubiquitinated species were allowed to accumulate for approximately 10 h. Cells were harvested by scraping in ice-cold PBS and pelleted and then lysed in denaturing buffer containing 50 mM TrisHCl, 0.5 mM EDTA, 1% SDS, and 1 mM dithiothreitol, followed directly by boiling for 10 min to avoid coimmunoprecipitation of another ubiquitinated protein(s). Lysates were diluted 10-fold in EBC (0.05 M Tris-HCl, pH 8.0, 0.12 M NaCl, 0.5% NP-40, 0.1 M NaF, 0.2 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml aprotinin) buffer, followed by immunoprecipitation with anti-p53 (FL-393).
Protein-protein interaction detection. Cells were harvested by scraping in ice-cold PBS and pelleted and then lysed in EBC. Cell extracts of 500 g of protein were first precleared with protein G-Sepharose beads for 1 h at 4°C and extracts were incubated with the appropriate antibody for 4 h. Protein complexes were precipitated by incubation with protein G-Sepharose beads overnight at 4°C. Precipitated complexes were washed four times with 1 ml of ELB ϩ buffer (0.25 M NaCl, 0.1% NP-40, 0.05 M HEPES, pH 7.0, 1 mM phenylmethylsulfonyl fluoride, 5 mM EDTA, and 0.5 mM dithiothreitol) and then resuspended in 2ϫ sample buffer and boiled for 8 min. Proteins were separated by SDS-PAGE and analyzed by Western blotting.
Protein interaction. Transcription-translation of mdm2 was performed with a TnT-coupled reticulocyte lysate system (Promega) for 35 S labeling using pcDNA3-myc3-HDM2 as the template DNA. Equal amounts of the resulting protein were mixed individually with 25 l of a complex of glutathione, Sepharose 4B, GST, and IE2-86 (described below) and its deletions at 4°C overnight in 0.3 ml of ELB ϩ buffer. Beads were washed with ELB ϩ buffer four times prior to boiling in 2ϫ SDS-PAGE loading buffer and Western blotting and autoradiography.
GST-IE2-86 and its deletions were expressed in Escherichia coli BL21 bacteria and purified with glutathione-Sepharose 4B. Expression from pGEX-2T vectors containing IE2-86 or its deletion cDNAs was induced in transformed BL21 cells with 0.5 mM isopropylthiogalactopyranoside (IPTG) for 2 h. Bacteria were centrifuged at 2,500 ϫ g for 10 min and pellets were resuspended in 1 ml cold PBS with 0.1 mM phenylmethylsulfonyl fluoride for each 10 ml of original culture. Suspensions were freeze-thawed three times, sonicated, and centrifuged at 13,000 ϫ g for 15 min. Supernatants were mixed with 25 l glutathioneSepharose 4B beads for 4 h at 4°C on a rocking platform. Beads were washed with 1 ml cold PBS with 0.1 mM phenylmethylsulfonyl fluoride four times. These complexes of glutathione, Sepharose, GST, and IE2-86 or its deletions were used for pulldown experiments.
Pulse-chase. H1299 cells were incubated to 80% confluence in 60-mm dishes and were transfected with 2 g of each expression plasmid indicated in The cells were scraped and washed twice with PBS and lysed in 300 l EBC buffer at 4°C on ice for 1 h. Lysates were mixed with extra 300 l EBL ϩ buffer and 25 l of protein G-Sepharose 4B for preclearance, and 0.5 g anti-p53 DO-1 or 0.5 g anti-mdm2 antibody was added. Samples were placed on a rocking platform at 4°C for 1 h, and 25 l protein G-Sepharose beads was added, and samples were gently mixed at 4°C for 3 h. Immunoprecipitation complexes were run out by SDS-PAGE and gels were dried and autoradiographed. The resulting films were analyzed with New ImageQuant TL v2003.01.
Reporter gene assays. BHK-21 cells were transfected with various combinations of plasmids as indicated using Effectene. Cells were grown in six-well plates and transfected when a density of 90% confluence was reached. A total of 1.0 g of DNA was used in each transfection. The mixture of vectors and Effectene reagent was added to the cells in 1.5 ml of DMEM without serum. Cells were incubated at 37°C and 6% CO 2 for an additional 18 h prior to dual luciferase assays that were performed according to the manufacturer's instructions (E1910; Promega). Firefly and Renilla luciferase activities were quantified on an LB 9501 luminometer (Berthold Technologies; Bad Wildbad, Germany) and raw data were normalized to the Renilla luciferase activities, which served as internal controls.
IE2-86 knockdown by siRNA. The short interfering RNA (siRNA) oligonucleotide 5Ј-AAACGCAUCUCCGAGUUGGACdTdT-3Ј and the complement 5Ј-GUCCAACUCGGAGAUGCGUUUdTdT-3Ј targeting HCMV IE2-86 were synthesized by Dharmacon (Lafayette, CO) as described previously (65) . We employed siRNA-Cy3 (QIAGEN) (sense sequence, UUCUCCGAACGUGU CACGUdTdT; 3Ј-Cy3) as a nonspecific control. HEL cells were grown to confluence in 100-mm dishes at 37°C in an atmosphere of 6% CO 2 and serum starved for 24 h. Dishes of cells were transfected with 10 l Lipofectamine 2000 and 5 l 20 M siRNA according to the manufacturer's instructions (Invitrogen). Four hours later cells were washed twice with DMEM and the medium was replaced with DMEM. Twenty-four hours posttransfection cells were infected with 2 to 5 PFU/cell HCMV. Six hours postinfection MG132 was added to the cell culture medium to a final concentration of 30 M, and plates were incubated an additional 10 h prior to harvesting for Western blot assays.
RESULTS
Status of mdm2 and p53 in HCMV-infected cells. We were unable to measure endogenous mdm2 levels in HEL fibroblasts by Western blotting (Fig. 1, lane 1 of upper panel) , presumably due to the low levels and/or high turnover rates described elsewhere for this protein (24, 37) . Mdm2 remained undetectable upon infection with HCMV (Fig. 1, lane 2 of upper panel) . In HCMV-infected cells treated with the proteasome inhibitor MG132, p53 and IE2-86 levels were higher than in HCMV-infected cells without MG132 (Fig. 1, lanes 2 and 4 of upper panel) . Mdm2 was detectable by Western blotting when uninfected cells were treated with MG132, yet mdm2 remained undetectable when HCMV-infected cells were treated with MG132 ( Fig. 1 , lanes 3 and 4 of upper panel).
Since mdm2 is known to function as a ubiquitin ligase and facilitate p53 ubiquitination and degradation (49), we examined the same system for ubiquitinated species of p53 by immunoprecipitation and Western blotting. Slowly migrating species of p53 consistent with ubiquitin conjugation were detected in uninfected cells treated with MG132 but little accumulated in the corresponding HCMV-infected cells (Fig. 1, lanes 3 and  4 of bottom panel) .
HCMV IE2-86 reduced both mdm2 levels and p53 ubiquitination. Previous reports have established (51) and we have reproduced the observation (data not shown) that p53 accumulation is detectable from 4 h post-HCMV infection of fibroblasts. This prompted examination of the effects of IE1-72 and IE2-86 upon p53 ubiquitination. Mammalian expression vectors encoding these immediate-early gene products, mdm2, and p53 from CMV promoters were transfected into H1299 (p53-null) cells. Slower-migrating species of p53 suggesting ubiquitination were reduced in cells transfected with IE2-86, mdm2, and p53 ( Regions of IE2-86 governing mdm2 depletion and p53 ubiquitination. To examine the domains of IE2-86 that downregulated mdm2, full-length and four deletion mutants of IE2-86 (pcDNA3IE2-26-579f, pcDNA3IE2-D325-448f, pcDNA3IE2-1-324f, and pcDNA3IE2-1-538f) were transfected into H1299 cells with mdm2 and p53 as indicated in Fig. 3 . The expression of Flag-tagged full-length and deletion IE2-86 proteins was confirmed by Western blotting (Fig. 3a) . Full-length IE2-86 and the mutant lacking amino acids 1 to 25 (IE2-26-579f) reduced the levels of mdm2 and stabilized those of p53 (Fig.  3a, lanes 3 and 4) , yet the other three (IE2-D325-448f, IE2-1-538f, and IE2-1-324f) mutants did not (Fig. 3a, lanes 5, 6, and  7) . When we immunoprecipitated p53, cells transfected with full-length IE2-86 and IE2-26-579f did not display slowly migrating species of p53 that would be consistent with ubiquitination (Fig. 3b, lanes 3 and 4) . Similarly, little mdm2 was detected in complex with p53 upon transfection with IE2-86 or IE2-26-579f (Fig. 3b, lanes 3 and 4) .
Immunoprecipitation of IE2-86 and its deletion mutants by their Flag epitopes allowed for the identification of interacting proteins. The mutant IE2-86 lacking amino acids 325 to 448 (IE2-D325-448f) was the most efficient at pulling down p53 despite slightly lower levels of p53 in this sample ( Fig. 3c and  a, lanes 5) . Full-length IE2-86 and those mutants lacking amino acids 1 to 25 (IE2-26-579f), 325 to 448 (IE2-D325-448f), or 539 to 579 (IE2-1-538f) coimmunoprecipitated p53 (Fig. 3c,  lanes 3, 4, 5, and 6 ), yet the 325 to 579 deletion mutant (IE2-1-324f) did not (Fig. 3c, lane 7) . Full-length IE2-86, IE2-26-579f, and IE2-1-538f coimmunoprecipitated mdm2 (Fig. 3d,  lanes 3, 4, and 6 ), yet mutants IE2-D325-448f and IE2-1-324f did not (Fig. 3d, lanes 5 and 7) . This was observed despite the lower levels of mdm2 in cells transfected with full-length IE2-86 and IE2-26-579f (Fig. 3a, lanes 3 and 4) . We observed a similar pattern when we immunoprecipitated mdm2 with anti-p53 (FL393) antibody (Fig. 3b, lanes 3 and 4) . mdm2 efficiently pulled down full-length IE2-86, IE2-26-579f, and IE2-1-538f (lanes 3, 4, and 6 in Fig. 3e) but not IE2-D325-448f or IE2-1-324f (Fig. 3e, lanes 5 and 7) . However, mdm2 coimmunoprecipitated p53 regardless of the presence or absence of IE2-86 and its mutants (Fig. 3f) .
Taken together, the data suggested that the putative zinc finger (amino acids 428 to 452) and/or acidic (amino acids 551 to 579) domain of IE2-86 (45) may be necessary for mdm2 reduction and the inhibition of p53 ubiquitination. Since IE2-D325-448f efficiently pulled down p53 (Fig. 3c, lane 5 ) but poorly bound mdm2 (Fig. 3d, lane 5) , and IE2-1-538 efficiently interacted with mdm2 ( Fig. 3d and e, lanes 6) but did not reduce mdm2 and inhibit p53 ubiquitination ( Fig. 3a and b , lanes 6), it appeared possible that the physical and functional interactions between IE2-86 and mdm2 might be independent of the described physical and functional associations between IE2-86 and p53 (60, 61) and between p53 and mdm2 (41) .
Direct interactions between IE2-86 and mdm2. To assess the possibility that IE2-86 might interact directly with mdm2 in the absence of p53 or other cellular factors, we employed cell-free pulldown experiments. GST-tagged full-length and deletion mutants of IE2-86 were expressed in E. coli BL21 and collected on glutathione-Sepharose beads. These beads were incubated with [
35 S]methionine-labeled mdm2 produced by in vitro transcription-translation. Complexes retained on beads were examined by autoradiography for mdm2 (Fig. 4A, upper panel) and by Coomassie blue staining to confirm the presence of IE2 species (Fig. 4A, bottom panel) . These results suggested that full-length IE2-86 and its mutants encoding amino acids 26 to 579 and 1 to 538 specifically interacted with mdm2 (Fig. 4A,  lanes 1, 2, and 3 of upper panel) and were consistent with the HCMV-infected cell experiments shown in Fig. 3 .
To investigate whether or not the specific interaction between IE2-86 and mdm2 could be reproduced in the context of an actual virus infection, cells were pretreated with 20 to 30 M MG132 for 10 h and then infected with HCMV for the analysis of mdm2-IE2-86 complexes by immunoprecipitation followed by Western blotting. We found that cells pretreated with MG132 poorly expressed IE2-86 upon infection (Fig. 4B,  lanes 3 and 4 of upper panel) . This was consistent with reports that pretreatment of cells with MG132 blocked HCMV activation of NF-B and virus infectivity (16, 17) . In order to provide a system where MG132-treated cells and virus-infected cells expressing IE2-86 could be examined together, we mixed the lysates of HCMV-infected cells with MG132-treated cells and subjected the mixture to immunoprecipitation followed by Western blotting (Fig. 4B, lanes 5 and 6 of bottom panel) . These conditions reproduced the mdm2-IE2-86 complexes observed by in vitro transcription-translation (Fig. 4A) .
IE2-86 blocked mdm2's transactivation of the cyclin A promoter. In order to substantiate the possibility that IE2-86's downregulation of mdm2 was independent of p53, we employed a reporter gene assay using firefly luciferase expression from a cyclin A promoter. mdm2 was shown to increase cyclin A promoter activity independently of p53 (40) . Figure 5 shows that mdm2 increased cyclin A promoter activity approximately sixfold in BHK-21 cells, similar to what was reported by others (40) . Cotransfection with IE2-86 blocked mdm2-dependent transactivation in a dose-dependent manner but did not affect basal levels of cyclin A promoter activity (Fig. 5, lanes 2, 3, 4 , (Fig. 5, lane 6) , while mutants IE2-D325-448f and IE2-1-538f did not reproducibly affect this system (Fig. 5, lanes  7 and 8) . These results suggested that IE2-86 specifically blocked mdm2-dependent, p53-independent transactivation of the cyclin A promoter. IE2-86 increased the half-life of p53 and reduced the halflife of mdm2. Since IE2-86 decreased and increased the steadystate protein levels of mdm2 and p53, respectively, independently of their endogenous promoters, we examined the effects of IE2-86 on the half-lives of mdm2 and p53. Pulse-chase experiments were performed with p53-transfected [
35 S]methionine-labeled H1299 cells cotransfected with combinations of mdm2, IE1-72, and IE2-86 expression vectors as described in the legend to Fig. 6 . As expected, the half-life of p53 was reduced when it was cotransfected with mdm2 ( Fig. 6A , compare a and b). When IE2-86 was cotransfected with p53 and mdm2, the effects of mdm2 on p53 were fully reversed (Fig.  6A , compare b and c) and the levels of mdm2 protein were reduced (Fig. 6B, compare b and c) . In contrast, IE1-72 did not change the effects of mdm2 on p53 (Fig. 6A and B, compare b  and d) . These results suggested that IE2-86 stabilized p53 via increasing its half-life independently of its effects upon the endogenous p53 promoter and possibly by assisting the degradation of mdm2.
We also performed pulse-chase experiments with mdm2-transfected [
35 S]methionine-labeled H1299 cells cotransfected with combinations of p53 and IE2-86 expression vectors. The half-life of mdm2 was increased upon cotransfection with p53 ( Fig. 7A and B , compare a and c) and decreased upon cotransfection with IE2-86 ( Fig. 7A and B, compare a and d) . Cotransfection with p53 and IE2-86 reduced the half-life of mdm2 ( Fig. 7A and B , compare a and b) in a manner indistinguishable from cotransfection with IE2-86 alone (Fig. 7A and B,  compare a and d) . Western blotting showed an increase in the steady-state levels of p53 when it was cotransfected with mdm2 and IE2-86 compared to the level with mdm2 alone, which correlated with decreased steady-state levels of mdm2 in the presence of IE2-86 (Fig. 7A or C, compare a with b and d) .
These experiments were repeated using IE2-86 deletion mutants in order to correlate these experiments with the above results. We found that the half-life of mdm2 was decreased in cells cotransfected with full-length IE2-86 and IE2-86 lacking amino acids 1 to 25 (IE2-26-579f) (Fig. 8A and B, b and c ), but not with any of the other corresponding deletion mutants employed ( Fig. 8A and B, d, e, and f) . These results suggested that IE2-86 directly decreased the half-life of mdm2 independently of p53 and that the putative zinc finger and/or acidic domain of IE2-86 was required for this effect.
IE2-86 depletion in HCMV-infected cells restored mdm2 induction. In order to determine the contribution of IE2-86 to mdm2 depletion in HCMV-infected cells, we intended to reproduce the above phenomena using recombinant viruses with IE2-86 deleted and/or mutated from infectious bacterial arti- The amounts of p53, mdm2, IE2-86, and IE1-72 were determined by immunoblotting at the indicated chase time points. "a" refers to transfection with p53, "b" refers to transfection with p53 and mdm2, "c" refers to transfection with p53 and mdm2-IE2-86, and "d" refers to transfection with p53 and mdm2 and IE1-72. ficial chromosome clones. However, IE2-86 knockouts have been reported and they are replication incompetent (46) . Therefore we employed an siRNA knockdown strategy reported previously (65) to significantly reduce IE2-86 expression in HCMV-infected cells. Treatment of HCMV-infected cells with IE2-siRNA disrupted IE2-86 expression, but not that of IE1-72 (Fig. 9, lanes 5 and 8) . Specificity was also confirmed using a negative control siRNA (Fig. 9, lanes 9 to 11) . In the context of HCMV infection, mdm2 levels accumulated upon IE2-siRNA and MG132 treatment (Fig. 9, lane 8) , but not without MG132 or IE2-siRNA treatment (Fig. 9, lanes 5 and  6) . The results suggested that only when the expression of IE2-86 was blocked could HCMV-infected cells accumulate measurable levels of mdm2 in response to MG132.
DISCUSSION
The aim of this study was to examine the status of mdm2 in cells productively infected with HCMV and its implications for the mechanism of p53 accumulation in virus-infected cells. The steady-state levels of mdm2 and presumably ubiquitinated species of p53 were decreased in response to HCMV infection in a proteasome-independent manner (Fig. 1) . These reductions in mdm2 and ubiquitinated p53 were reproducible upon transfection of cells with IE2-86 but not with IE1-72 (Fig. 2) . IE1-72 and IE2-86 share the same 85 N-terminal amino acids and are splice variants of the UL123 and 122 genes (11) . Our examination of the regions of IE2-86 responsible for perturbation of the mdm2-p53 autoregulatory loop suggested that the putative zinc finger and C-terminal acidic domains were important for mdm2 downregulation. IE2-86 amino acids 326 to 449 were required for mdm2 binding and reducing the half-life of mdm2, while amino acids 540 to 579 were required to reduce the half-life of mdm2 but not for mdm2 binding.
The unique regions of IE1-72 and IE2-86 (exons 4 and 5, respectively) have similar sequences that suggest zinc finger motifs (amino acids 428 to 452), yet their orientations (H 2 C 2 and C 2 H 2 , respectively) are opposite (27) . The primary amino acid sequence of IE2-86 also suggests the possibility of a double zinc finger or Lin-11, Isl-1, and Mec-3 (LIM) domain from residues 428 to 480 (CX 5 CX 11 HX 5 HX 9 DXCX 13 HXH) (Fig.  10A) . LIM domains are multiple binding and adapter modules containing specialized double zinc finger motifs that are important for protein-protein interactions (5) . These are responsible for key interactions with coactivators, corepressors, competitors, and other transcription factors and are therefore of con- It is possible that the zinc finger/LIM domain of IE2-86 may mediate not only binding to mdm2, but also other proteinprotein interactions potentially facilitating mdm2 degradation, such as interacting with the RING-H2 zinc finger protein RLIM (5) . It was reported that the putative IE2-86 zinc finger (from C428 to H452) had no effect upon DNA binding, but H446L and H452L IE2-86 mutants were unable to bind DNA (4). It is possible that these mutations disrupted the putative LIM domain.
Also important for IE2-86 downregulation of mdm2 was the C-terminal acidic domain. The last 37 amino acids of IE2-86 have been shown to contain a transferable transactivation domain that is required for transactivation, autoregulation, and DNA binding (4, 13, 30) . The acidic domains of other proteins were important for ubiquitination reactions (6, 42) , suggesting the possibility of a role for this region of IE2-86 in catalysis. An IE2-86-mdm2 complex might recruit another coactivator(s), corepressor(s), kinase(s), or component(s) responsible for protein degradation by synergy of its zinc finger/LIM and acidic domains. While the specific function(s) of the identified IE2-86 domains remains speculative, the data indicated that both the zinc finger/LIM and acidic domains of IE2-86 were required to bring about mdm2 degradation. IE2-86 mutants IE2-D325-448 (zinc finger/LIM domain damage), IE2-1-324 (both zinc fin- ger/LIM and acidic region removal), and IE2-1-538 (acidic domain removal) were unable to cause mdm2 degradation (Fig. 3, 5, and 8) .
Given that IE2-86 and mdm2 were known to bind at least five proteins in common (see introduction), it seemed reasonable to expect that these two proteins would be capable of coimmunoprecipitation. As shown in Fig. 3 and 4B, this prediction was validated. Pulldown experiments with in vitrotranslated protein were employed to examine the binding properties of the isolated proteins. It was much more surprising that IE2-86 and mdm2 were capable of interactions in the absence of other cellular proteins (Fig. 4A) . The inabilities of mutants GST-IE2-D325-448 and GST-IE2-1-324 to pull down mdm2 suggested that the binding was specific (Fig. 4A) .
We examined five events that occurred in the p53-mdm2 regulatory loop in response to full-length and deletion mutants of IE2-86 (Fig. 10B) . The IE2-D325-448 mutant bound p53 but not mdm2, suggesting distinct binding interactions for IE2-86-p53 and IE2-86-mdm2. Binding of IE2-86 to mdm2 was insufficient to block functional transactivation of the cyclin A promoter by mdm2 or to prevent p53 ubiquitination. The mutants of IE2-86 that were capable of binding mdm2 and downregulating its functions were the same as those that reduced the half-life of mdm2. This suggested that IE2-86-mediated functional downregulation of mdm2 resulted from mdm2 degradation.
The ability of IE2-86 to cause mdm2 depletion independent of mdm2's endogenous promoter suggested that regulation was not at the transcriptional level. It is not clear how IE2-86 facilitated mdm2 degradation. The inability to recover mdm2 in the presence of MG132 suggested that this phenomenon was proteasome independent. Since the binding of IE2-86 to mdm2 was not sufficient to degrade mdm2, it is possible that other functions of IE2-86 are required for mdm2 degradation. Possible functions include those that might mediate subcellular localization, catalysis, conformational changes, or the recruitment of another protein(s) that might degrade mdm2.
Since p53 transcriptional activity controls mdm2 expression and IE2-86 likely blocks p53 transcriptional activity, it seems unnecessary for HCMV to employ IE2-86 to facilitate mdm2 degradation. An apparent duplication of functions is also employed by HCMV to block cellular apoptosis. At least five cytomegalovirus proteins (vMIA, vICA, m41, IE1-72, and IE2-86) are independently capable of blocking apoptosis (9, 28, 56, 66, 71) . vICA is dispensable for viral growth in cell culture (56) and IE1-72 is not required for efficient HCMV replication at high multiplicities of infection (29) . This is consistent with the proposal that degenerate or multiple viral solutions to host countermeasures may be important virulence factors in vivo (2) and are not unique to mdm2. An alternative explanation is that p53 transcriptional activity may not be absent in HCMVinfected cells. Transfection of fibroblasts with IE2-86 did not prevent the induction of p53, mdm2, and p21 by actinomycin D, nor did it block cell cycle arrest (7, 44) .
Another interesting question is how mdm2 depletion might facilitate HCMV replication. If the p53 induced by HCMV infection is not functional, then at issue are the p53-independent effects of mdm2. Several speculative explanations follow. HCMV IE1-72 and IE2-86 bring about the disruption of promyelocytic leukemia (PML) associated nuclear bodies (ND10 or PML oncogenic domains) causing diffuse nuclear redistribution of PML; however, IE2-86 alone does not disrupt ND10 (1) . Coexpression of mdm2 with PML causes nuclear exclusion of PML (62) and thus could block a potentially important event in HCMV replication.
There is evidence to suggest that HCMV may alter the cell cycle of infected cells to a state resembling late G 1 to facilitate viral replication (18, 63) . In limited systems mdm2 stimulated S-phase progression (20, 48) and thus functional mdm2 could alter the balance toward cellular rather than viral proliferation. The Sp1 transcription factor is stimulated in productive HCMV infection (67) . mdm2 binds Sp1 and blocks Sp1 transcriptional activity (35) but can be reversed by Rb (35) . A virion protein, pp71, causes degradation of Rb and related proteins (38) . However, the accumulation of Rb during HCMV infection (32) suggests that downregulation of mdm2 to facilitate Sp1 induction may not be a sustained viral replication strategy. We also note that the fact that an event occurs during productive viral replication is not prima facie evidence that the event is conducive to viral replication. Infrequently they are not. For example, systematic gene deletions of the HCMV genome revealed that removal of 4 out of 162 genes resulted in enhanced viral fitness (21) .
We have shown that mdm2 levels were decreased in HCMVinfected cells due to accelerated degradation and that the viral IE2-86 protein was likely responsible. The interactions between IE2-86 and mdm2 appeared to be specific and occurred in the absence of other candidate adaptor molecules. HCMV infection results in cellular DNA damage (22) and the activation of signal transduction pathways that could be responsible for p53 accumulation. For example, HCMV infection or IE1-72 transfection induced ataxia telangiectasia-mutated kinase-dependent p53 phosphorylation on residue Ser 15 (10) . However, others reported that in HCMV-infected cells or IE2-86-expressing cells there was a direct correlation between the relative amount of p53 and the relative amount of p53 phosphorylation (58) . The data presented here suggest an alternative mechanism: p53 accumulation via IE2-86-dependent mdm2 degradation (Fig. 11 ). This mechanism is likely to play an important role in the context of HCMV infection because siRNA-mediated knockdown of IE2-86 restored the accumulation of mdm2 (Fig. 9 ).
